Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Jan 30, 2026
Purchase
Shares
28,100
Price
$0.89
Total Value
$25.01K
Shares Held After
373,720
% of Holdings
7.5%
Jan 30, 2026
Sale
Shares
6,612
Price
$18.11
Total Value
$119.74K
Shares Held After
365,273
% of Holdings
1.8%

Nurix Therapeutics, Inc. (NRIX)

Hansen Gwenn — Chief Scientific Officer
Jan 30, 2026
Sale
Shares
98
Price
$17.37
Total Value
$1.70K
Shares Held After
83,672
% of Holdings
0.1%

Nurix Therapeutics, Inc. (NRIX)

Hansen Gwenn — Chief Scientific Officer
Jan 30, 2026
Sale
Shares
4,797
Price
$16.58
Total Value
$79.55K
Shares Held After
83,770
% of Holdings
5.4%

Nurix Therapeutics, Inc. (NRIX)

van Houte Hans — Chief Financial Officer
Jan 30, 2026
Sale
Shares
73
Price
$17.37
Total Value
$1.27K
Shares Held After
45,427
% of Holdings
0.2%

Nurix Therapeutics, Inc. (NRIX)

van Houte Hans — Chief Financial Officer
Jan 30, 2026
Sale
Shares
3,588
Price
$16.58
Total Value
$59.50K
Shares Held After
45,500
% of Holdings
7.3%

Nurix Therapeutics, Inc. (NRIX)

Ring Christine — Chief Legal Officer
Jan 30, 2026
Sale
Shares
88
Price
$17.37
Total Value
$1.53K
Shares Held After
57,010
% of Holdings
0.2%

Nurix Therapeutics, Inc. (NRIX)

Ring Christine — Chief Legal Officer
Jan 30, 2026
Sale
Shares
4,333
Price
$16.58
Total Value
$71.85K
Shares Held After
57,098
% of Holdings
7.1%
Version: v26.3.33